INEOS Enterprises, a leading global chemical manufacturer of specialty and intermediate chemicals, announced that it has signed an agreement to acquire MBCC Group’s Admixture Business from Sika. The admixture business is a leading producer of concrete additives essential for the construction industry, with well invested operations across 35 manufacturing sites and sales of around USD […]
As we have informed here, the Swiss investor Capvis, which specialises in medium-sized investments, acquires a majority stake in the Lucerne-based SCHURTER Group. The founding and previous owner family continues to hold a stake in
Niederer Kraft Frey advised Diebold Self-Service Solutions, a member of the Diebold Nixdorf group, as Swiss counsel on the refinancing of certain debt and on the provision of USD 400 million in new capital for the
As we have informed here, Invision, a renowned investment company focusing on succession solutions and growth financing for medium-sized companies in German-speaking countries, has launched and successfully closed Invision Logistics LP, a CHF 145m continuation
Niederer Kraft Frey advised Capvis, the specialist in mid-market investments and a well-known Swiss investor, on the investment into AdEx Partners. The growth strategy will be further enhanced through expansion of the service portfolio, internationalization,
On January 5, 2023, BioVersys announced that the AMR Action Fund has joined existing investors of BioVersys, extending the total proceeds of the Series C round to CHF 32.6 million. The Swiss pharma company represents the first European-based
The first edition of “Mergers & Acquisitions” co-edited by Florian S. Jörg (partner at Bratschi, pictured left), Urs Gnos (partner at Walder Wyss, pictured center) and Schellenberg Wittmer corporate/m&a partner Lorenzo
CVC and Partners Group have entered into an agreement for Partners Group to increase its stake in leading Swiss watchmaker Breitling in a transaction that will make it the company’s largest shareholder. Upon completion
As we have informed here NLS Pharmaceutics, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announced that it has
Investindustrial, a leading European group in the field of private equity, has signed an agreement through one of its investment vehicles for the entry of QuattroR into the capital of Medical Technology and Devices Group.
